Browse
Submit Data
Databases
API
Help

Dataset Information

11 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mimivirus in pneumonia patients.

ABSTRACT: Mimivirus, the largest virus known to date, is an amebal pathogen-like Legionella sp. When Mimivirus was used as an antigen in a microimmunofluorescense assay, seroconversion was found in patients with both community- and hospital-acquired pneumonia. Mimivirus DNA was found in respiratory samples of a patient with hospital-acquired pneumonia.

SUBMITTER: La Scola B

PROVIDER: S-EPMC3298252 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Screening pneumonia patients for mimivirus.

Project description:Acanthamoeba polyphaga mimivirus (APM), a virus of free-living amebae, has reportedly caused human respiratory disease. Using 2 newly developed real-time PCR assays, we screened 496 respiratory specimens from 9 pneumonia-patient populations for APM. This virus was not detected in any specimen, which suggests it is not a common respiratory pathogen.

| S-EPMC2570813 | biostudies-literature

PCR Detection of Mimivirus.

Project description: Not available

| S-EPMC5443443 | biostudies-literature

Mimivirus battle19

Project description:Mimivirus battle19 Genome sequencing

| PRJNA281323 | ENA

Mimivirus amazonia

Project description:Mimivirus amazonia Genome sequencing

| PRJNA281378 | ENA

Mimivirus battle27

Project description:Mimivirus battle27 Genome sequencing

| PRJNA281326 | ENA

Mimivirus terra2

Project description:Mimivirus terra2 Genome sequencing

| PRJNA212557 | ENA

Mimivirus battle86

Project description:Mimivirus battle86 Genome sequencing

| PRJNA281335 | ENA

Mimivirus battle83

Project description:Mimivirus battle83 Genome sequencing

| PRJNA281334 | ENA

Mimivirus T6

Project description:Mimivirus T6 Genome sequencing and assembly

| PRJNA278018 | ENA

DNA methylation profiles in pneumonia patients reflect changes in cell types and pneumonia severity

Project description:Immune cell type composition changes with age, potentially weakening the response to infectious diseases. Profiling epigenetics marks of immune cells can help us understand the relationship with disease severity. We therefore leveraged a targeted DNA methylation method to study the differences in a cohort of pneumonia patients (both COVID-19 positive and negative) and unaffected individuals from peripheral blood. This approach allowed us to predict the pneumonia diagnosis with high accuracy (AUC = 0.92), and the PCR positivity to the SARS-CoV-2 viral genome with moderate, albeit lower, accuracy (AUC = 0.77). We were also able to predict the severity of pneumonia (PORT score) with an R2 = 0.69. By estimating immune cellular frequency from DNA methylation data, patients under the age of 65 positive to the SARS-CoV-2 genome (as revealed by PCR) showed an increase in T cells, and specifically in CD8+ cells, compared to the negative control group. Conversely, we observed a decreased frequency of neutrophils in the positive compared to the negative group. No significant difference was found in patients over the age of 65. The results suggest that this DNA methylation-based approach can be used as a cost-effective and clinically useful biomarker platform for predicting pneumonias and their severity.

2022-03-18 | GSE192702 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data